7LEZ image
Deposition Date 2021-01-15
Release Date 2021-09-01
Last Version Date 2024-10-30
Entry Detail
PDB ID:
7LEZ
Title:
Trimeric human Arginase 1 in complex with mAb1 - 2 hArg:2 mAb1 complex
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
4.15 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Arginase-1
Gene (Uniprot):ARG1
Chain IDs:D (auth: A), E (auth: B), F (auth: C), I (auth: M), J (auth: N), K (auth: J)
Chain Length:322
Number of Molecules:6
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:mAb1 heavy chain
Chain IDs:A (auth: D), L (auth: G), M (auth: R), N (auth: Q)
Chain Length:455
Number of Molecules:4
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:mAb1 light chain
Chain IDs:B (auth: E), C (auth: I), G (auth: P), H (auth: O)
Chain Length:214
Number of Molecules:4
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of action.
Commun Biol 4 927 927 (2021)
PMID: 34326456 DOI: 10.1038/s42003-021-02444-z

Abstact

Human Arginase 1 (hArg1) is a metalloenzyme that catalyzes the hydrolysis of L-arginine to L-ornithine and urea, and modulates T-cell-mediated immune response. Arginase-targeted therapies have been pursued across several disease areas including immunology, oncology, nervous system dysfunction, and cardiovascular dysfunction and diseases. Currently, all published hArg1 inhibitors are small molecules usually less than 350 Da in size. Here we report the cryo-electron microscopy structures of potent and inhibitory anti-hArg antibodies bound to hArg1 which form distinct macromolecular complexes that are greater than 650 kDa. With local resolutions of 3.5 Å or better we unambiguously mapped epitopes and paratopes for all five antibodies and determined that the antibodies act through orthosteric and allosteric mechanisms. These hArg1:antibody complexes present an alternative mechanism to inhibit hArg1 activity and highlight the ability to utilize antibodies as probes in the discovery and development of peptide and small molecule inhibitors for enzymes in general.

Legend

Protein

Chemical

Disease

Primary Citation of related structures